Denali Therapeutics, Inc. (DNLI)
24.20
-0.72
(-2.89%)
USD |
NASDAQ |
Aug 24, 16:00
23.73
-0.47
(-1.94%)
After-Hours: 20:00
Denali Therapeutics Total Return Level : 24.20 for Aug. 24, 2026
Total Return Level Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Return Level Data
| Date | Value |
|---|---|
| August 24, 2026 | 24.20 |
| August 21, 2026 | 24.92 |
| August 20, 2026 | 24.95 |
| August 19, 2026 | 25.69 |
| August 18, 2026 | 24.31 |
| August 17, 2026 | 24.35 |
| August 14, 2026 | 24.40 |
| August 13, 2026 | 24.82 |
| August 12, 2026 | 25.27 |
| August 11, 2026 | 24.69 |
| August 10, 2026 | 25.00 |
| August 07, 2026 | 24.83 |
| August 06, 2026 | 24.73 |
| August 05, 2026 | 24.42 |
| August 04, 2026 | 24.17 |
| August 03, 2026 | 23.15 |
| July 31, 2026 | 23.02 |
| July 30, 2026 | 24.35 |
| July 29, 2026 | 23.85 |
| July 28, 2026 | 24.05 |
| July 27, 2026 | 23.57 |
| July 24, 2026 | 23.11 |
| July 23, 2026 | 23.42 |
| July 22, 2026 | 23.64 |
| July 21, 2026 | 23.83 |
| Date | Value |
|---|---|
| July 20, 2026 | 22.90 |
| July 17, 2026 | 23.29 |
| July 16, 2026 | 22.73 |
| July 15, 2026 | 23.02 |
| July 14, 2026 | 22.65 |
| July 13, 2026 | 26.48 |
| July 10, 2026 | 25.68 |
| July 09, 2026 | 27.21 |
| July 08, 2026 | 26.69 |
| July 07, 2026 | 26.31 |
| July 06, 2026 | 25.74 |
| July 02, 2026 | 25.83 |
| July 01, 2026 | 25.98 |
| June 30, 2026 | 25.72 |
| June 29, 2026 | 25.89 |
| June 26, 2026 | 25.57 |
| June 25, 2026 | 24.73 |
| June 24, 2026 | 24.82 |
| June 23, 2026 | 24.77 |
| June 22, 2026 | 24.05 |
| June 18, 2026 | 23.31 |
| June 17, 2026 | 23.49 |
| June 16, 2026 | 21.93 |
| June 15, 2026 | 22.22 |
| June 12, 2026 | 21.66 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 86.73 |
| Biogen, Inc. | 218.12 |
| Oncolytics Biotech, Inc. | 0.8441 |
| Sangamo Therapeutics, Inc. | 0.16 |
| Sarepta Therapeutics, Inc. | 18.13 |